Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» myelofibrosis
myelofibrosis
Geron rises on 2Q results and imetelstat update
Yahoo/AP
Sat, 08/10/13 - 12:08 pm
Geron
earnings
imetelstat
myelofibrosis
Incyte Drug Jakafi® (ruxolitinib) Improved Overall Survival in Phase III Trial of Patients with Myelofibrosis
Yahoo/BusinessWire
Sun, 06/16/13 - 11:33 am
Incyte
clinical trials
Jakafi
myelofibrosis
Incyte's Jakafi Is Likely A $1 Billion Drug
Seeking Alpha
Thu, 02/28/13 - 11:35 am
Jakafi
Incyte
myelofibrosis
Phase II Trial of Sanofi JAK2 Inhibitor in Myelofibrosis Met Primary Endpoint
Yahoo/PR Newswire
Sun, 12/9/12 - 11:32 am
Sanofi
myelofibrosis
SAR302503
Incyte looks to ride on drug's success
The News Journal, DE
Sun, 05/6/12 - 11:44 am
Incyte
Jakafi
myelofibrosis
polycythemia
YM Biosciences: The Next Way To Get Long Myelofibrosis
Seeking Alpha
Thu, 05/3/12 - 10:58 am
YM BioSciences
myelofibrosis
Novartis
Eli Lilly
Incyte
CYT387
Is YM the Next Incyte?
Minyanville
Mon, 12/19/11 - 02:19 pm
Incyte
YM BioSciences
CYT387
myelofibrosis
YM Bio's Myelofibrosis Drug Is For Real
TheStreet.com
Tue, 12/13/11 - 09:31 am
YM BioSciences
myelofibrosis
CYT387
Incyte CEO Touts Prospects of New Cancer Drug
Minyanville
Sat, 11/19/11 - 11:38 am
Jakafi
Incyte
myelofibrosis
F.D.A. Approves Drug for Bone Marrow Disease
NY Times, NY
Thu, 11/17/11 - 09:09 am
FDA
myelofibrosis
bone marrow disorder
Jakafi
JAK inhibitors
Incyte
The Big Bet on YM BioSciences
Motley Fool
Thu, 09/1/11 - 12:14 pm
YM BioSciences
myelofibrosis
ruxolitinib
CYT387
Novartis
Incyte
Incyte Reports Additional Analyses of Symptomatic Improvement and Quality of Life with Ruxolitinib (INC424) in Patients with Myelofibrosis from the COMFORT-I Study
BusinessWire
Sun, 06/12/11 - 10:36 am
Incyte
ruxolitinib
myelofibrosis
With promising Ph3 data in hand, Incyte files for myelofibrosis drug OK
Fierce Biotech
Mon, 06/6/11 - 12:31 pm
Incyte
myelofibrosis
ruxolitinib
Incyte Announces Ruxolitinib (INC424) Shows Significant Clinical Benefit for Myelofibrosis Patients in Two Phase III Studies at ASCO Annual Meeting
Yahoo/BusinessWire
Sun, 06/5/11 - 10:03 am
Incyte
ruxolitinib
INC424
myelofibrosis
Incyte and YM Biosciences in Race to Market Strongest JAK Inhibitor
Seeking Alpha
Thu, 04/21/11 - 11:46 am
JAK inhibitors
YM BioSciences
Incyte
myelofibrosis
Novartis maps out a blockbuster future for INC424
Fierce Biotech
Wed, 03/16/11 - 09:21 am
Novartis
INC424
Incyte
JAK inhibitors
ruxolitinib
myelofibrosis
Incyte: Myelofibrosis Drug Looks Promising
Seeking Alpha
Mon, 12/27/10 - 08:29 am
Incyte
myelofibrosis
Virgin Market for New Bone Marrow Cancer Drug
Minyanville
Sat, 11/27/10 - 12:32 pm
Incyte
myelofibrosis
YM BioSciences
CYT387
ONYX Pharmaceuticals
Odds Increase for Approval of Incyte's Myelofibrosis Drug
Seeking Alpha
Wed, 09/29/10 - 11:40 am
Incyte
myelofibrosis
Novartis
Pages
« first
‹ previous
1
2
3